Skip to content
GSIGSIGSI

Drawing based on the label description. No photo yet.

“The tablets are white, capsule shaped, film coated and debossed with "GSI" on both sides”

GSI pill

Pill with imprint GSI is white, capsule, 19 mm and has been identified as Emtricitabine, Rilpivirine Hydrochloride, and Tenofovir Disoproxil Fumarate 200 mg / 25 mg / 300 mg. It is used for HIV. It is supplied by Gilead Sciences, Inc.

Emtricitabine, Rilpivirine Hydrochloride, and Tenofovir Disoproxil Fumarate 200 mg / 25 mg / 300 mg

Imprint
GSI
Strength
Emtricitabine 200 mg / Rilpivirine 25 mg / Tenofovir Disoproxil Fumarate 300 mg
Used for
HIV
Color
White
Shape
Capsule / oblong
Size
19 mm
Score
No score line
Form
Tablet, film coated
Manufacturer
Gilead Sciences, Inc
Drug class
HIV medicine
NDC
61958-1102, 61958-1102-5

Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Emtricitabine, Rilpivirine Hydrochloride, and Tenofovir Disoproxil Fumarate pills and guides

What is Emtricitabine, Rilpivirine Hydrochloride, and Tenofovir Disoproxil Fumarate used for?

Emtricitabine, Rilpivirine Hydrochloride, and Tenofovir Disoproxil Fumarate is used for HIV.

Medicine type
HIV medicine
Official uses from the US prescribing label

COMPLERA™ is indicated as a complete regimen for the treatment of HIV-1 infection in adults and pediatric patients weighing at least 35 kg:

  • as initial therapy in those with no antiretroviral treatment history with HIV-1 RNA less than or equal to 100,000 copies/mL at the start of therapy or
  • to replace a stable antiretroviral regimen in those who are virologically suppressed (HIV-1 RNA less than 50 copies/mL) on a stable antiretroviral regimen for at least 6 months with no treatment failure and no known substitutions associated with resistance to the individual components of COMPLERA.

Limitations of Use:

  • More rilpivirine-treated subjects with HIV-1 RNA greater than 100,000 copies/mL at the start of therapy experienced virologic failure (HIV-1 RNA ≥50 copies/mL) compared to rilpivirine-treated subjects with HIV-1 RNA less than or equal to 100,000 copies/mL.

From the FDA-approved label on DailyMed (published Jul 25, 2025).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • Your pill shows GSI.
  • It is white, capsule, 19 mm.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Sold under the brand name Complera Access.

Ingredients

Active: Emtricitabine, Rilpivirine Hydrochloride, Tenofovir Disoproxil Fumarate

Inactive: Microcrystalline Cellulose, Lactose Monohydrate, Povidone, Unspecified, Polysorbate 20, Croscarmellose Sodium, Magnesium Stearate, Starch, Corn, Hypromellose, Unspecified, Titanium Dioxide, Triacetin, Water

Other pills with imprint GSI

Same imprint, different listing. Check the color, size and maker against your pill.

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.